Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
Acorda, advocated, aforementioned, alliance, aminopyridine, AMPYRA, AMPYRATM, ANCA, Angell, ANGIOX, ANTEGREN, Antineutrophil, ARZERRATM, assay, ASUNo, asymptomatic, authoritative, Babson, baminercept, BELONG, binomial, Bioscience, Biotechnologie, Biovitrum, cardiopulmonary, Carl, Carlo, Caroline, category, ceased, certolizumab, cGCP, cheaper, chlorambucil, CIMZIA, CINEMA, clotting, Codification, composed, Contingenciesto, creditworthy, cytoplasmic, dalfampridine, declizumab, deconsolidating, Denner, Detailto, devise, Dispositionsand, Dispositionsto, distressed, Dodge, Dorsa, dual, earliest, easier, efficient, Eidetica, element, Eli, EMA, Equityto, expedited, expend, ExpenseswithinCritical, extinguished, fampridine, fast, Fenner, fieldwork, FILM, flu, Foundation, FUMADERMtm, gas, GATT, Genzyme, Glaxo, Goldman, golimumab, GPC, Hoescht, housing, Immunex, inclusive, incorrectly, increasingly, Informationto, input, insignificant, Instrumentsto, irritable, JC, JDC, Kabushiki, Kaisha, Language, laquinimod, latitude, lifetime, Lilly, LN, lock, LUCID, Lytton, Measurementsto, mefloquine, Mellon, military, Monte, Moody, Mulligan, multiplied, multiplier, nonfinancial, noninferiority, nonqualified, nonrecognizable, Obama, Oncovin, ONCOVINTM, opportunistic, opportunistically, orderly, Ortho, OtherTopic, outbreak, outlook, Oxford, Pacific, Palmer, pandemic, passage, pediatric, pegol, Pierce, Plansto, plasma, Policiesto, presumption, prompt, Pronouncementsto, properly, prorated, prosecuting, ramp, rapidly, RAVE, recapture, recharacterizing, reclassification, RecognitionTopic, recognizable, red, redosing, refiling, region, reinformed, relieved, reluctant, retail, revealing, Richard, routinely, rule, safer, screening, SCRIPT, SecuritiesTopic, Seiyaku, serological, seropositive, seventeen, ShareTopic, SIMPONI, SIMPONITM, simulation, stop, stopped, sublease, subsidy, successor, Sunshine, supervisory, tagged, theConsolidationTopic, theEarning, theInvestment, therevenue, tier, tiered, titer, toValuation, transferor, TRICARE, Trust, twenty, unamortized, unanimously, undelivered, underperformance, uninterrupted, unpaid, unpromoted, unrelated, unreliable, unused, USPTO, vacancy, vacate, walking, whichever, WilmerHale, writ, XBRL, XIII
Removed:
AAA, abnormal, accomplish, achieve, acid, add, administer, aggressively, AHP, Alan, Alnylam, alpha, altered, amending, Answering, APB, ARB, arterial, Arzneimittel, assertion, assignment, assisting, attack, Attorney, attribute, Austria, autoimmune, back, background, backup, Belgium, binding, bioavailable, biopharmaceutical, breached, broaden, broader, Budget, CA, called, capable, cGMP, chemical, Chiron, CHOP, Classen, closing, closure, coincident, collateralized, collectively, computer, Concurrent, constitute, constituted, consummate, contending, contingently, conversely, converted, convict, cooperating, copromote, copromotion, correct, correctly, Council, dating, deem, demyelinating, depreciated, derecognition, desirable, diagnostic, discontinuance, discontinued, discover, discretion, display, distinct, distributed, diversification, diversify, divestiture, Division, DLBCL, dominant, Eastern, EMEA, employ, employer, enable, encoding, episode, escrowed, Esq, EU, existence, extending, FAS, fatal, favor, FCR, fibroblast, FileNo, fill, FIN, Finland, fontolizumab, Frameworkissued, frequently, FSP, fulfilling, fumarate, fumaric, furniture, geldanamycin, gene, genetic, Glassberg, goal, GP, great, hardware, Head, headcount, heat, Home, honor, hormone, HuZAF, hypertension, immunization, improvement, indigent, Indirect, induced, inducing, influenced, informed, infringement, ingredient, inhibitor, inInternal, initiate, initiative, innovative, Institute, intention, interpretation, INTRON, investigative, IPO, KG, kit, Kogyo, lab, labeled, Lawrence, lawsuit, leasing, legacy, lengthy, lesser, light, living, LP, machinery, malignant, marketer, materialize, medicine, mentioned, Millennium, Modernization, mondo, monthly, motion, move, MPM, myeloma, network, Neuroscience, NICO, nonexclusive, noninfringement, Norway, Notwithstanding, occupy, occurrence, Oceanside, onset, orally, Overview, PAH, paragraph, patenting, PDL, peginterferon, Phillip, PHS, plaintiff, Portugal, post, postretirement, preexisting, Primatized, proof, proportion, proportioned, pulmonary, quantified, ranging, rapid, rapidity, reassessed, REBETOL, REBETRON, reconciled, reintroduction, release, relocation, remission, removal, Rescission, reserving, respiratory, restatement, restructuring, resumed, ribavirin, RNAi, room, RTP, sanction, Santhera, satisfaction, sBLA, score, secondary, Sharp, shock, situation, SLE, software, spend, stand, statistically, stipulated, strategically, strongly, studied, submitting, subscription, supervise, supplementary, supportive, sustained, Sweden, synthetic, Taniguchi, Tanox, targeting, technical, thisForm, transplant, unavoidable, undermining, understating, unexpected, unforeseen, varying, velcade, Vetter, violating, virtue, VP, week, West, Wyeth, Zenyaku
Filing tables
Filing exhibits
- 10-K Annual report
- 10.50 EX-10.50 Transition Agreement, Dated As of January 4, 2010
- 10.52 EX-10.52 Letter Regarding Employment Arrangement of Robert Hamm Dated April 1, 2009
- 10.58 EX-10.58 Letter Regarding Employment Arrangement of Susan Alexander Dated December 13, 2005
- 21 EX-21 Subsidiaries
- 23 EX-23 Consent of Pricewaterhousecoopers LLP
- 31.1 EX-31.1 Section 302 Certification of the Chief Executive Officer
- 31.2 EX-31.2 Section 302 Certification of the Chief Financial Officer
- 32.1 EX-32.1 Section 906 Certification of the Chief Executive Officer and the Chief Financial Officer
- Download Excel data file
- View Excel data file
Related press release
BIIB similar filings
Filing view
External links
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-4 (No. 333-107098) and Registration Statements on Form S-8 (Nos. 333-97211, 333-106794, 333-47904, 333-65494, 333-110432, 333-110433, 333-128339, 333-152456, 333-128339 and 333-140817) of Biogen Idec Inc. of our report dated February 9, 2010 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
February 9, 2010
February 9, 2010